Glia-based neuroprotection strategies are emerging as promising new avenues to treat brain damage. We previously reported that activation of the glial-specific purinergic receptor, P2Y 1 R, reduces both astrocyte swelling and brain infarcts in a photothrombotic mouse model of stroke. These restorative effects were dependent on astrocyte mitochondrial metabolism. Here, we extend these findings and report that P2Y 1 R stimulation with the purinergic ligand 2-methylthioladenosine 5 0 diphosphate (2MeSADP) reduces and partially reverses neuronal damage induced by photothrombosis. In vivo neuronal morphology was confocally imaged in transgenic mice expressing yellow fluorescent protein under the control of the Thy1 promoter. Astrocyte mitochondrial membrane potentials, monitored with the potential sensitive dye tetra-methyl rhodamine methyl ester, were depolarized after photothrombosis and subsequently repolarized when P2Y 1 Rs were stimulated. Mice deficient in the astrocyte-specific type 2 inositol 1,4,5 trisphosphate (IP 3 ) receptor exhibited aggravated ischemic dendritic damage after photothrombosis. Treatment of these mice with 2MeSADP did not invoke an intracellular Ca 2 þ response, did not repolarize astrocyte mitochondria, and did not reduce or partially reverse neuronal lesions induced by photothrombotic stroke. These results demonstrate that IP 3 -Ca 2 þ signaling in astrocytes is not only critical for P2Y 1 R-enhanced protection, but suggest that IP 3 -Ca 2 þ signaling is also a key component of endogenous neuroprotection.
INTRODUCTION
A cerebrovascular stroke is the rapid loss of brain function(s) due to disturbance in the blood supply to the brain. This can be due to ischemia caused by blockage or to a hemorrhage. Strategies to minimize brain damage and enhance neurological recovery after stroke have focused almost exclusively on neurons and resulted in minimal success. Recent evidence points to astrocytes as an alternative candidate for the development of novel stroke therapies. 1 Astrocytes are the most abundant cell type in the human brain and they are more resistant to ischemia than neighboring neurons. They naturally support neuronal survival and modulate neuronal recovery by providing metabolic and trophic support, glutamate and K þ clearance, as well as antioxidant protection during ischemia. 2 In fact, the size of the ischemic infarct appears to be largely determined by the extent of astrocyte death. 2 Consequently, we have targeted astrocytes to enhance neuronal survival and minimize persistent brain damage after stroke.
At its core, cell death after stroke results from reduced oxygen and glucose, which decreases ATP production. 3 ATP depletion increases the influx of Na þ ions into cells followed by Cl À ions. This influx increases osmotic pressure and causes cell lysis if the blood supply is not rapidly restored. The most prominent astrocyte response to brain damage is cell swelling. 4 Na þ influx also depolarizes cells, which stimulates an excessive release of the neurotransmitter glutamate in excitatory neurons causing excitotoxicity. 5 In general, excitotoxicity and cell lysis subsequent to osmotic expansion damage adjacent tissue and expand the infarct by secondary mechanisms. 2, 6 Although an ample supply of energy is fundamental to the ability of astrocytes to carry out their neuroprotective functions, it has only recently been demonstrated that astrocyte mitochondria play an important role in energy production. 7, 8 Chu et al 9 reported that inhibition of glial mitochondria increases astrocyte swelling and leads to necrotic cell death. We reported a major protective role for astrocyte mitochondria subsequent to oxidative stress and stroke in mice. 10, 11 We also reported P2Y 1 R stimulation decreased cytotoxic edema in astrocytes and lessened the size of brain infarcts. 11 In this manuscript, we extend these studies and show that P2Y 1 R stimulation of astrocyte mitochondrial metabolism also enhances neuronal survival and recovery after stroke. In addition, we establish the critical role of IP 3 R-mediated Ca 2 þ signaling on this protective pathway. Given the pervasive energy demands of neuroprotective mechanisms, we propose that therapeutic strategies targeting astrocyte mitochondrial metabolism will be broadly applicable to multiple types of brain damage. selectively expresses YFP in cortical layer 5 pyramidal neurons were obtained from The Jackson Laboratory (Bar Harbor, ME, USA) and bred at the University of Texas Health Science Center at San Antonio animal facilities. The IP 3 R2 knockout mice were generated by Dr Ju Chen's group at the University of California-San Diego and obtained from Dr Ken McCarthy's laboratory at the University of North Carolina at Chapel Hill. Experimental procedures were identical to our previously published protocols. 11 Animal procedures were carried out in accordance with the Institutional Animal Care and Use Committee (IACUC) at University of Texas Health Science Center at San Antonio (Animal Welfare Assurance Number: A3345-01) and with the ARRIVE guidelines. 12 Mice were anesthetized with isofluorane and their body temperature was maintained at 37 1C by a heating pad (Gaymar T/Pump). Their scalp was shaved and incised in the midline. Then the skull was exposed, cleaned and glued (VetBond, 3M, St Paul, MN, USA) to a stainless steel ring attached to a custom-made stereotaxic frame. A small portion of the skull overlying the somotosensory cortex (between B1 to B3 mm postbregma and 2 to 4 mm lateral) was initially thinned by variable-speed electric drill (Fine Science Tools, Foster City, CA, USA) and further thinned to B50 mm by a surgical blade to either create a thin-skull cranial window or an open-skull cranial window by removing the skull using a fine-tipped forceps (0.01 mm, Dumont, Fine Science Tools). To achieve an open-skull window, subsequent manual removal of the dura with a fine-tipped forceps was carefully performed under aCSF (artificial cerebrospinal fluid) containing 126 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 2 mM MgCl 2 , 2 mM CaCl 2 , 10 mM glucose, and 26 mM NaHCO 3 (pH 7.4). Then the cortical surface was washed and the cranium hole sealed by filling it with 2% agarose (type VII, low gelling temperature, Sigma, St Louis, MO, USA). A glass coverslip (#0) was then pressed against the skull to allow optimal imaging with a high numerical objective (60 Â LUMFL NA 1.1 with correction collar, Olympus, Tokyo, Japan).
Stroke Induction by Rose Bengal Photothrombosis and Drug Administration
Photochemical reaction of Rose Bengal activates tissue factor, the initiator of the coagulation cascade, and consequently triggers the extrinsic coagulation cascade, therefore producing an ischemic lesion that is pathologically very relevant to clinical stroke. Focal cerebral ischemic stroke was induced by photochemical thrombosis as previously described. 11 In brief, 10 mg/mL sterilized Rose Bengal dissolved in PBS (phosphate-buffered saline) (Sigma) was tail-vein injected. Photothrombosis was performed by exposing a targeted cortical arteriole (20 to 30 mm) to green light (543 nm, 5 mW) through a 0.8-NA 40 Â water-immersion objective (Nikon, Tokyo, Japan). Stable clot formation was confirmed by occlusion of downstream capillaries. According to our previous studies, the blood-brain barrier breaks down within 10 minutes of an RB-induced ischemic stroke and remains disrupted for at least 2 days following photothrombosis. 11 Loss of the blood-brain barrier allowed us to introduce pharmacological reagents at the same time a stroke was induced. P2Y 1 R-specific agonists 2MeSADP (0.25 mg/kg, 100 mM) was administrated by tail-vein injection.
Neuronal Dendrite Imaging, Astrocyte Ca 2 þ and Dc Imaging
In vivo imaging was performed as previously described 11 by utilizing an Olympus FV1000 MPE with a 10 Â 0.45 NA dry, 40 Â 0.8 NA or 60 Â 1.1 NA water objective. For neuronal dendritic imaging, high-resolution z stacks of layer one cortical dendrites containing a clotted vessel were acquired before and after RB-induced, ischemic stroke. Dendritic beading was quantified following the procedures outlined by Dr Murphy's group. 13, 14 In brief, maximal intensity projections of cortical Z stacks were performed preclot, postclot and post-2MeSADP to obtain two-dimensional (D) images under each condition. These 2D images were registered and aligned using stackreg of NIH Image J software (National Institutes of Health, Bethesda, MD, USA) to facilitate identification and comparison of same dendrites. The preclot image was utilized as a reference and colored green. The images of postclot and post-2MeSADP cortex were colored red and merged with the green preclot image. The merged green À red images were utilized to count beading percentage manually using Grid and Cell counter plugins of image J. A grid of 20 Â 20 mm 2 blocks was overlaid on a merged green À red image for analysis. Blocks with blebbed dendrites were identified, counted and reported as a beading percentage utilizing Cell counter. We note that blebbed dendrites were larger in diameter than their corresponding reference dendrites and exhibited a typical 'string of beads' appearance as previously reported. 13, 14 For calcium imaging, the exposed mouse cortex was incubated with cytosolic Ca 2 þ indicator dye Fluo4-AM. Fluo4-AM was dissolved in 5 mL DMSO mixed with 2 mL of Pluronic and diluted in 30 mL artificial cerebral spinal fluid (aCSF). Following 1-hour incubation, the excess dye was washed off by aCSF. The cortical loading of Fluo4-AM is highly specific for astrocyte labeling in vivo. 15 For mitochondrial membrane potential imaging, potential sensitive dye tetramethyl rhodamine methyl ester (TMRM) was dissolved in DMSO, diluted in sterilized PBS (100 mM) and tail-vein injected. Tetra-methyl rhodamine methyl ester is a lipophilic cation indicator that equilibrates across membranes in a Nernstian fashion. It accumulates in the mitochondrial matrix in inverse proportion to the mitochondrial membrane potential. 16 Consequently, tail-vein injections of TMRM permeate the blood-brain barrier and label brain mitochondria. Presumably because of their proximity to blood vessels, our data indicate that tail-vein loading of TMRM preferentially labels astrocyte mitochondria. We demonstrated that TMRM-stained peri-nuclear mitochondria colocalize with cells that can be labeled with the astrocyte-specific dye sulforhodamine 101 (SR101) 15 as shown in Figures  4D and 4F . To correct for spectral overlap in Figures 4D and 4F , the TMRM image at 6 hours was subtracted from the SR101 plus TMRM image at 7 hours after RB photothrombosis. This correction procedure assumes minimal movement of TMRM-labeled mitochondria during the 1-hour labeling period with SR101 dye. We checked and confirmed the lack of significant movement by observing essentially no TMRM fluorescent signal outside of SR101-labeled astrocytes in the final corrected image. We noted that astrocytes can be identified in the absence of SR101 staining because of their large-round nuclei ( Figure 3 ). This observation is consistent with images being acquired in layer 1 of the cortex, where very few neuronal nuclei exist and the size of microglia nuclei are significantly smaller. 17 Consequently, their size and abundance make astrocyte nuclei very distinctive. This approach showed no significant influence on neuronal dendrite and astrocyte morphology ( Figure 3 ). Cortical application of 100 mM FCCP significantly decreased TMRM fluorescence with 30 seconds ( Figure 3C ), suggesting a nonquench staining pattern of TMRM. We initially assigned single mitochondria to specific astrocytes by using GFAP-GFP transgenic mice and subsequently found that bright circular nuclei of GFPlabeled astrocytes were completely colocalized with large, dark, rounded nuclei of Hoechst loaded cells ( Figures 3A and 3B ). This typical staining pattern of TMRM in cortical astrocytes was utilized to identify astrocytes and their mitochondria in Thy1-YFP mice. The virtual absence of significant movement of mitochondria in vivo enabled real-time measurements of Dc. Estimates of Dc were made as previously described. 10 Dc is expressed as the ( À 60 mV)log(Fmito/Fcyto), where Fmito is the peak fluorescent intensity observed in single mitochondria and Fcyto represents the lowest value of TMRM fluorescence observed over nuclei. The confocal excitation and emission spectra for fluorescent dyes are as following: TMRM was excited at 543 nm, and emission was collected through a 565 to 615 nm barrier filter. YFP was excited using a 514-nm argon laser line and the emission was collected between 535 to 580 nm. Fluo4-AM was excited at 488 nm and emission was collected through a 500 to 540 nm barrier filter. Hoechst 33342 was excited at 405 nm and emission was collected through a 420 to 460 nm. SR101 was excited with a HeNe green laser (543 nm) and detected in the 590 to 680 nm range.
Neuronal Lesions Evaluation Following Photothrombotic Stroke
As previously described, 11 in vivo assessment of ischemic neuronal lesions was performed by measuring the infarction border identified by the absence of YFP fluorescence and the absence of 2,3,5-triphenyltetrazolium chloride (TTC) staining. Multiple overlapping Z-stacks with 2 mm stepsize were taken from nearby region of clotted vessel 24 hours postthrombosis on Thy1-YFP transgenic mice, IP 3 R2 KO-Thy1-YFP mice and littermate controls. Mosaic reconstruction of maximum intensity projections of overlapping image stacks was performed by using MosaicJ plug-in of NIH imageJ software to determine the infarction border.
Statistical Analyses
One-way analysis of variance was used to compare the differences among three or more groups. t-Test was used to compare the difference between two groups. The significance level is set at Po0.05. Data are presented as mean±standard error (s.e.) of the mean. Prism software (Graphpad, La Jolla, CA, USA) was used to perform statistical analyses.
RESULTS

P2Y 1 R Stimulation Reduces RB-Induced Ischemic Neuronal Lesions in Mouse
As previously reported, we significantly reduced the size of cerebral infarcts induced by photothrombosis by stimulating Energized glial mitochondria reverse brain damage W Zheng et al astrocyte-specific P2Y 1 Rs with the purinergic ligand 2-methylthioladenosine 5 0 diphosphate (2MeSADP). 11 These studies were performed in transgenic mice expressing GFP in astrocytes, which permitted us to define the size of a lesion as the absence of GFP fluorescence (cell lysis). TTC staining of cortical infarcts was also performed in these previous studies to confirm loss of GFAP-GFP fluorescence accurately defined lesions following RB photothrombosis. Here, we wanted to determine how P2Y 1 R stimulation affected neuronal viability after ischemic damage. To accomplish this, we optically imaged layer one of the cerebral cortex of transgenic mice expressing YFP in neurons (Thy1-YFPH) using previously described protocols. 11 When single-vessel ischemic clots were induced by irradiation of tail-vein-injected Rose Bengal (RB), we observed swelling and beading of dendritic structure in the absence of neuronal death ( Figures 1A and 1B ). These morphological changes are an early hallmark of ischemic neuronal injury as initially reported by Li and Murphy in 2008. Twenty-four hours after the photothrombosis, neuronal cell death, that is cell lysis, was apparent and an infarction border could easily be identified by the absence of YFP-labeled dendrites near the clotted blood vessel ( Figure 1C ). Again, we confirmed the validity of defining lesions as the absence of YFP fluorescence by TTC staining (Figures 1E, 1G , and 1H) and costaining with a nuclear DNA stain, Hoechst ( Supplementary Figure 1) . The extent of neuronal loss, 18.1±0.8 mm 2 Â 10 4 (n ¼ 4) at 24 hours was significantly larger than the lesion defined by astrocyte death 10.2 ± 0.7 mm 2 Â 10 4 (n ¼ 5). These data were consistent with previous studies in cell culture, as well as those of others, 18 indicating cortical astrocytes were more resistant to ischemia than neurons in vivo ( Supplementary Figure 2) . To test the impact of 19 Normal morphology can be rescued by early restoration of blood flow after ischemia. 13 In contrast, if left unchecked, progression of dendrite beading and swelling leads to dendritic loss and neuronal cell death. A key requirement for recovery appears to be an adequate energy supply. 19 Consequently, we tested whether P2Y 1 R stimulation could reverse ischemic dendritic injury. A single-vessel clot was induced with photothromobisis, then dendritic swelling and beading were permitted to develop. Three hours after the initial photothrombosis, 2MeSADP was tail-vein injected into the ischemic mouse. We observed significant reversal of dendritic beading and swelling within 1 hour of 2MeSADP treatment, which continued for at least another 2 hours (Figures 2A-2C ). 13 we note that neither laser illumination nor the RB dye by itself affected dendrite beading (data not shown).
P2Y 1 R-Enhanced Neuroprotection Correlates with Reversal of RB-Induced Mitochondrial Depolarization in Astrocytes
Our previous studies indicated that P2Y 1 R-mediated neuroprotection depends on astrocyte mitochondrial metabolism. 11, 20 This mechanism predicts that ischemia-induced changes in dendritic morphology correlate with changes in astrocyte mitochondrial potentials. To test this prediction, Thy1-YFP mice were prepared for in vivo imaging as previously described and then tail-vein injected with the potential sensitive dye TMRM (0.1 mL of 100 mM TMRM). This procedure rapidly labels all mitochondria within minutes, with TMRM fluorescence remaining stable for at least 3 hours ( Figures 3D-3H ). Subcellular images of individual mitochondria in the proximity of YFP-labeled neuronal dendrites were recorded using this technique ( Figure 4A ). A subpopulation of mitochondria near morphologically distinct nuclei was attributed to astrocytes based on the observations that neuronal nuclei are generally absent in layer one of the cortex and that microglial nuclei are significantly smaller than astrocyte nuclei labeled with GFP or SR101 ( Figures 3A and 3B and 4F) . When a single vessel, RB-induced photothrombosis was induced, we observed significant mitochondrial depolarization in parallel with dendritic beading and swelling ( Figures 4B, 4G-4I ). The mean mitochondrial potential decreased from À 146.8 ± 6.0 (n ¼ 3) in control cells to À 122.3 ± 6.3 (n ¼ 3) 3 hours after photothrombosis ( Figure 4J ). When the P2Y 1 R ligand, 2MeSADP, was tail-vein injected at 3 hours postclot, we observed a significant repolarization of astrocyte mitochondria to À 148.3 ± 5.0 (n ¼ 3), as well as a partial reversal of the neuronal beading and swelling ( Figures 4C and 4E) . A control mouse in which saline was tail-vein injected at 3 hours postclot exhibited continued mitochondrial depolarization and dendritic damage ( Figures 4G-4I) .
Reversal of RB-Induced Mitochondrial Depolarization in Astrocytes
We demonstrated that P2Y 1 R-enhanced neuroprotection can be pharmacologically blocked by treating astrocytes with the mitochondrial Ca 2 þ uniporter inhibitor, ruthenium360, with the ATP synthesis inhibitor, oligomycin, as well as with the tricarboxylic acid cycle inhibitor, fluoroacetate. 11, 20 We have also reported that P2Y 1 R-enhanced neuroprotection can be genetically blocked by expression of a mitochondrially targeted DNA restriction enzyme, mtEcoR1, which specifically disrupts astrocyte mitochondrial function. 11 Here, we directly tested whether the P2Y 1 R-enhanced mitochondrial metabolism was dependent on the inositol 1,4,5 trisphosphate receptor (IP 3 R). IP 3 R type2 knockout mice were utilized, since their astrocytes lack spontaneous and G-protein coupled receptor mediated Ca 2 þ increases. 21 IP 3 R type2 knockout or control wild-type mice were prepared for in vivo cortical imaging using an open-skull preparation, which permitted cortical loading of the Ca 2 þ indicator dye Fluo-4 AM. 22 Mice were then treated and imaged as described above, including tail-vein injection of rose Bengal (RB) and 2MeSADP (100 mM). We found that after an RB-induced photothrombosis, leakage of 2MeSADP across the blood-brain barrier elicited Ca 2 þ increases in astrocytes in control wild-type mice ( Figures 5A and 5B ), but not in IP 3 R type2 knockout mice ( Figures 5C and 5D) , consistent with the observations of Petravicz and coworkers. 21 The average peak amplitude of wild-type astrocytic Ca 2 þ responses within 50 mm of the clotted vessel was 0.76 ± 0.09 (DF/F, n ¼ 3 mice pooled from 51 cells). Direct measurements of the blood vessel diameter, before (32.3 ± 4.2, n ¼ 6) and after (31.8±5.1, n ¼ 7) astrocytic Ca 2 þ revealed no acute changes in the vasculature. Next, we crossed IP 3 R type2 knockout mice with Thy1-YFP mice to enable in vivo imaging of neuronal morphology and then tail-vein injected the potential sensitive dye TMRM to determine the impact of IP 3 R type2 activity on mitochondrial membrane potentials. We found no significant differences in astrocyte mitochondrial membrane potentials under basal conditions, with and without IP 3 Rs type2. In contrast, after we challenged these mice with an RB-induced ischemic stroke, the mitochondrial membrane potential in astrocytes from IP 3 R type2 knockout mice was found to be significantly lower than littermate controls 3 hours postphotothrombosis. The average potential was ( À 107.6 ± 6.3 mV, n ¼ 3) in IP 3 R type2 astrocytes and ( À 122.3 ± 6.3 mV, n ¼ 3) in wild-type, control mice ( Figures  6E-6H cf. Figures 4G-4J , data pooled from three mice). Moreover, administration of 2MeSADP, 3 hours after the initial photothrombosis, failed to reverse the RB-induced mitochondrial depolarization in astrocytes in IP 3 R type2 knockout mice ( Figures 6A-6D) .
These experiments indicate that IP 3 -Ca 2 þ signaling plays a critical role not only in mediating P2Y 1 R-enhanced mitochondrial metabolism, but also in enhancing mitochondrial metabolism postischemia in the absence of 2MeSADP.
Astrocyte IP 3 -Mediated Ca 2 þ Release Is Required for P2Y 1 R-Mediated Decreases in RB-Induced Ischemic Neuronal Lesions and Dendritic Damage Finally, we wanted to directly test whether the P2Y 1 R-enhanced neuroprotective pathway was dependent on the IP 3 R type2. We again utilized the IP 3 R2 knockout x Thy-YFP mice and measured the effect of RB-induced ischemic lesions. First, we found that the average size of RB-induced ischemic lesions in IP 3 R type2 knockout mice, even in the absence of P2Y 1 R stimulation, was significantly increased to 52.7 ± 4.9 mm 2 Â 10 4 (n ¼ 4) This represented a 195.2%±16.1% increase compared with littermate wild-type controls at 24 hours postphotothrombosis ( Figure 7A , cf. Figure 1C) . Second, we found no evidence that the average size of RB-induced neuronal lesions at 57.6±4.2 mm 2 Â 10 4 (n ¼ 4) was changed at 24 hours, when mice were tail-vein injected with 2MeSADP ( Figures 7B and 7C ). Third, we determined that delayed treatment of mice with 2MeSADP, 3 hours after the initial RB-induced photothrombosis, failed to reduce or partially reverse the neuronal dendritic beading and swelling ( Figures 7D-7H ).
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We concluded that P2Y 1 R-enhanced neuroprotection and partial reversal of dendritic damage is dependent on expression of the IP 3 R type2 in astrocytes.
DISCUSSION
Astrocyte-mediated neuroprotection after brain damage is gaining wide acceptance. 1 We previously reported that neuroprotection could be enhanced by stimulating astrocyte-specific P2Y 1 Rs. This enhanced protection could be blocked by inhibitors of mitochondrial Ca 2 þ uptake (Ru360) and ATPsynthase activity (oligomycin). 20 Measurements showed that P2Y 1 R stimulation, as well as direct addition of membrane permeable IP 3 to astrocytes, increased mitochondrial O 2 consumption and ATP production. 20 The in vivo neuroprotective effects appeared to act by increasing mitochondrial metabolism and not by affecting vasodilation, clot stability or microglia. 11 Our working model assumes that stimulation of P2Y 1 Rs generates IP 3 , which binds to the IP 3 R, releasing Ca 2 þ from the endoplasmic reticulum. We further assume that Ca 2 þ is sequestered by mitochondria, ultimately leading to increased ATP production by increasing the membrane potential via stimulation of Ca 2 þ -sensitive dehydrogenases in the tricarboxylic acid cycle and the ATPsynthase. Ca 2 þ -stimulated production of ATP was initially characterized in cardiac muscle mitochondria, which increased energy production up to 10-fold faster than stimulation by ADP. 23 Here, we tested and extended Energized glial mitochondria reverse brain damage W Zheng et al our model in four important ways. We directly demonstrated that P2Y 1 R stimulation of astrocytes reduced neuronal damage and cell death. We determined that ischemia-induced brain damage and swelling were partially reversed by P2Y 1 R stimulation. We established that enhanced neuroprotection correlated with increased mitochondrial metabolism in astrocytes. Finally, we demonstrated that all of these P2Y 1 R-stimulated actions depended on astrocyte-specific IP 3 R expression. IP 3 -mediated Ca 2 þ release in astrocytes has long been recognized as a major component of the early ischemic response. 24 However, the functional implications of Ca 2 þ following ischemia have not been resolved, with both protective and detrimental effects identified. Several groups reported that IP 3 -Ca 2 þ signaling counteracted the development of ischemic brain edema via its role in regulatory volume decrease. 25 These data are consistent with the findings we presented here and previously. 11 On the other hand, Ding et al 26 demonstrated that astrocyte Ca 2 þ signaling increased excitotoxic neuronal injury following ischemia, possibly via the Ca 2 þ -dependent release of glial glutamate. Their data and ours are not necessarily contradictory and may simply reflect multiple Ca 2 þ targets within astrocytes as well as differential Ca 2 þ responses related to either receptor subtype or the location and duration of a Ca 2 þ response. For example, Shigetomi et al 27 found stimulation of both P2Y 1 Rs and proteinase-activated receptors (PAR-1s) increased intracellular Ca 2 þ in astrocytes, but only activation of PAR-1s resulted in significant release of glutamate from astrocytes and neuronal toxicity. Shigetomi et al 27 suggested that this was related to the modes of glutamate exocytosis triggered by these agonists, the spatial location of the glutamate release sites or the duration of the Ca 2 þ transients. The time scale and magnitude of the Ca 2 þ response may also be critical. Photothrombotic ischemia can induce significant Ca 2 þ increases in astrocytes but this generally takes much longer than the time frame we observe P2Y 1 R-induced changes (Figures 5A and 5B) . Specifically, Ding et al 26 showed that it takes B30 to 40 minutes to observe significant increases in somatic Ca 2 þ increases after a large photothrombosis. In contrast, our P2Y 1 R ligand 2MeSADP, introduced via tail injection, increased astrocyte Ca 2 þ within 10 minutes.
The studies presented here have further defined the neuroprotective role of astrocyte IP 3 -Ca 2 þ signaling in the ischemic brain by utilizing a mouse model deficient in the only IP 3 R isoform expressed in astrocytes, the IP 3 R2. 21 These knockout mice exhibit no significant changes in Ca 2 þ -dependent gliotransmitter release under normal conditions and there do not appear to be any histological or behavioral abnormalities. 21 We found the size of ischemic lesions was not reduced by P2Y 1 R stimulation in IP 3 R2 knockout mice and delayed treatment of these mice with the P2Y 1 R ligand 2MeSADP did not reverse dendritic damage. We concluded that P2Y 1 R-enhanced neuroprotection was dependent on IP 3 R2 signaling. It should be noted, however, that the size of photothrombotic-induced ischemic lesions was increased in the absence of the IP 3 R2 isoform, even in the absence of P2Y 1 R stimulation (Figure 7) . This observation is comparable to the data we previously reported showing disruption of mitochondrial function in astrocytes, either pharmacologically or genetically, resulted in larger ischemic lesions in the absence of P2Y 1 R Figure 5 . Tail-vein injection of 2MeSADP induces Ca 2 þ increases in wild-type control astrocytes after photothrombosis, but not in astrocytes of IP 3 R2 KO mice. (A) Confocal images of the Ca 2 þ responses in wild-type control mice loaded with the Ca 2 þ indicator fluo4-AM before RB-induced photothrombosis, and 3 and 10 minutes after RB photothrombosis. Clotted vessel appears in the middle panel (red pixels with label). Ca 2 þ levels (fluo4 fluorescence) are color-coded (blue is lowest concentration, red is highest concentration). The Ca2 þ levels of three cells (identified by dashed circles) are followed before and after 2MeSADP leakage across the blood-brain barrier. stimulation. 11 It is also clear that extracellular ATP concentrations are increased following ischemia, 28 which would be expected to activate purinergic receptors in astrocytes. Taken together, these data are consistent with an endogenous neuroprotective mechanism in astrocytes activated after ischemia, inhibited by disruption of either basal IP 3 R signaling or mitochondrial function and mediated, at least in part, by naturally stimulated P2Y 1 Rs. Depolarization and repolarization of astrocyte mitochondria potentials were correlated with the extent of both dendritic beading and swelling after photothrombotic ischemia. The assignment of cortical layer I mitochondria to astrocytes was based on the distinctive size, shape and abundance of astrocytes at layer I cortex where very few neuronal nuclei exist and the size of microglia nuclei are significantly smaller than astrocytes. 17 The accuracy of assignment was suggested by either GFP labeling from GFAP-GFP mice or astrocyte-specific dye SR101. In addition, the accuracy of assigning nuclear-associated mitochondria to astrocytes was independently tested in mice with specific genetic disruptions limited to astrocytes only. Stimulation of astrocytespecific P2Y 1 Rs repolarized nuclear-associated mitochondria 3 hours after photothrombosis in control mice (Figure 4 ). However, P2Y 1 R stimulation had no affect on polarization of these nuclearassociated mitochondria in transgenic mice with astrocyte-specific knockout of IP 3 R signaling (IP 3 R 2 knockout mice) ( Figure 6 ). We observed that the average mitochondrial membrane potential was near À 150 mV at rest and was reduced to B À 120 mV at 3 hours, when dendritic damage was very pronounced (Figure 4 ). 2MeSADP treatment repolarized mitochondria to resting levels (B À 150 mV) in parallel to the partial reversal of dendritic damage (Figure 4 ). Consistent with our working model of astrocyte-mediated neuroprotection, postischemic treatment of IP 3 R2 knockout mice with 2MeSADP did not reverse dendritic beading and swelling and did not repolarize astrocyte mitochondrial membrane potentials ( Figure 6 ). We found no evidence that the resting mitochondrial membrane potentials in astrocytes were affected by the absence of IP 3 R2 signaling (cf. Figures 6E-6H and Figures 4G-4J ). However, photothrombotic lesions of IP 3 R2 knockout mice appeared to result in greater depolarization with an average potential closer to B À 110 mV at 3 hours, before treatment with 2MeSADP ( Figure 6 ). These data also suggest that IP 3 R2-dependent signaling mediates an endogenous neuroprotective mechanism in astrocytes.
An obvious requirement for mitochondrial oxidative phosphorylation after stroke is the availability of oxygen and an energy substrate. Our observations, as well as reports by others, have shown collateral vessels nearby clotted vessels continue to flow to provide oxygen and glucose, albeit at lower level than control values. 11, 13, 29 Moreover, the glucose metabolic rate in acute penumbral tissue is not decreased despite significant blood flow reduction, thus leading to a markedly elevated metabolism/blood flow ratio. Glycogen stores in astrocytes may also serve as a carbon source during glucose deprivation. 30 The repolarization of astrocyte mitochondria by applying 2MeSADP after single-vessel photothrombosis indicates the supply of both oxygen and energy is adequate, regardless of the source.
That a variety of GPCRs (G-protein-coupled receptors) can stimulate IP 3 -mediated Ca 2 þ release in astrocytes is well documented. 31 We reported that treatment of astrocytes with membrane permeant IP 3 alone is sufficient to stimulate mitochondrial metabolism. 20 Thus, each GPCR is expected to enhance neuroprotection when activated. However, it is important to select a GPCR that is expressed only in astrocytes, for example P2Y 1 Rs, 11, 32 since IP 3 -mediated increases in mitochondrial Ca 2 þ in many cell types, including neurons, opens the mitochondrial permeability transition pore causing necrosis. Astrocytes as well as muscle cells are much less sensitive to Ca 2 þ -induced necrosis, likely due to low expression levels of cyclophilin D. 33 This makes P2Y 1 Rs a promising target to regulate glial metabolism and improve brain damage outcome. Moreover, we found no evidence that stimulation of P2Y 1 Rs induced significant, Ca 2 þ -sensitive glutamate release from astrocytes, and consequently, its stimulation may not generate excitotoxic NMDA receptormediated inward currents in neurons. 27 Kazuhide Inoue and coworkers 34 have reported that stimulation of P2Y 1 Rs enhances long-term neuroprotection by upregulating oxidoreductase genes and stimulating interleukin 6 release. They also reported long-term neurodestructive effects after P2Y 1 R stimulation that appeared linked to a p-RelA-mediated NF-kB pathway that modulated the transcriptional activity of cytokine/ chemokine. 35 Protective versus destructive transcriptional responses of P2Y 1 R stimulation may be due to the different injury models utilized in these studies: permanent ischemia versus an ischemia-reperfusion. Reperfusion after ischemia leads to a significant burst of oxidative damage absent in permanently occluded blood vessels. 36 Nevertheless, our approach is distinct in that most of our experimental data were obtained acutely (nontranscriptionally) and after permanent occlusion of blood vessels. This distinction is important to emphasize with regard to our observation that P2Y 1 R stimulation partially reversed ischemia-induced dendritic damage, since reperfusion itself has been shown to reverse dendritic beading and swelling. 14, 19 Overall, our data suggest that the neuroprotective effects of P2Y 1 R stimulation are most likely due to astrocyte-specific expression even though P2Y 1 Rs have been reported expressed in multiple cells types, including interneurons, microglia, and endothelial cells. 37 First, we found that expression of P2Y 1 Rs appears higher in astrocytes compared with other cell types when immunoprobed in mouse brain slices. 32 These data do not rule out an affect of P2Y 1 R expression in other cell-types, but they are consistent with astrocytes being more sensitive to P2Y 1 R stimulation. Irrespective of P2Y 1 R levels in other cell types, the neuroprotective effects that we observe appear dependent on astrocyte expression. In particular, pharmacological and genetics manipulations indicate that astrocyte mitochondrial function is required for P2Y 1 R-enhanced neuroprotection: an astrocytespecific tricarboxylic acid cycle toxin, fluoroacetate, blocked neuroprotection and expression of a astrocyte-specific, mitochondrially targeted DNA restriction enzyme, EcoRI, blocked neuroprotection. 11 Furthermore, we demonstrated in this manuscript that P2Y 1 R-enhanced neuroprotection was dependent on expression of an IP 3 R2 isoform that is primarily expressed in astrocytes ( Figures 6 and 7) . Independently, we measured the effect of P2Y 1 R stimulation on vasodilation and found no significant changes, suggesting that neuroprotection was unlikely mediated by endothelial cells. 11 Finally, all of the genetic manipulations noted above blocked P2Y 1 R-enhanced repolarization of mitochondria associated with astrocyte nuclei, as argued above. Based on these data, we suggest that P2Y1R-enhanced neuroprotection is mediated by astrocyte-specific expression.
The specific, ATP-dependent process in astrocytes that benefits neurons remains to be elucidated. Candidate processes range from an ATP-dependent production of soluble factors, such as synthesis and release of glutathione or brain-derived neurotrophic factor, 4 to an ATP-dependent restoration of ion homeostasis. Acutely, control of Na þ and K þ ion levels by Na þ , K þ ATPase activity may be critical. Increased activity of this pump after ischemia would reduce the buildup of intracellular Na þ ions and consequently, decrease cytotoxic edema, as originally suggested by our previous study. 11 Edema not only increases pressure on neurons, but restricts blood flow, further exacerbating ischemic conditions. 38 Increased Na þ , K þ ATPase activity would also enhance the ability of astrocytes to reduce elevated extracellular K þ after ischemia, which would inhibit the occurrence of damaging recurrent spreading depolarizations in both neurons and astrocytes. 5, 39 Recurrent spreading depolarizations are known to play a critical role in the expansion of cerebral infarcts. 6, 40 They Energized glial mitochondria reverse brain damage W Zheng et al elevate metabolic stress in the penumbra primarily due to the increased energy demands required to recovery ion homeostasis. Recurrent spreading depolarizations also depolarize excitatory neurons, stimulating an excessive release of the neurotransmitter glutamate leading to excitotoxicity. 5 In general, excitotoxicity and cell death subsequent to disruption of ion homeostasis damages adjacent tissue and expand the infarct by secondary mechanisms. 2 Irrespective of the affected end process, our results suggest that stimulation of astrocyte ATP production is potentially a robust therapeutic strategy to treat brain damage, since it is not inherently dependent on protecting or affecting a single target within neurons.
